| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 3 | | | |
| | | | 8 | | | |
| | | | 14 | | | |
| | | | 16 | | | |
| | | | 22 | | | |
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT | | | | | | | |
| | | | 30 | | | |
| | | | 33 | | | |
| | | | 38 | | | |
| | | | 39 | | | |
| | | | 39 | | | |
| | | | 40 | | |
| | |
As of April 19, 2022
|
| |||||||||||||||||||||||||||
Total Number of Directors
|
| |
7
|
| |||||||||||||||||||||||||||
| | |
Female
|
| |
Male
|
| | | | | | | |
Non-
Binary |
| |
Did Not
Disclose Gender |
| ||||||||||||
Part I: Gender Identity | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Directors
|
| | | | 2 | | | | | | 5 | | | | | | | | | | | | — | | | | | | — | | |
Part II: Demographic Background | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
African American or Black
|
| | | | — | | | | | | — | | | | | | | | | | | | — | | | | | | — | | |
Alaskan Native or Native American
|
| | | | — | | | | | | — | | | | | | | | | | | | — | | | | | | — | | |
Asian
|
| | | | — | | | | | | 3 | | | | | | | | | | | | — | | | | | | — | | |
Hispanic or Latinx
|
| | | | — | | | | | | — | | | | | | | | | | | | — | | | | | | — | | |
Native Hawaiian or Pacific Islander
|
| | | | — | | | | | | — | | | | | | | | | | | | — | | | | | | — | | |
White
|
| | | | 2 | | | | | | 2 | | | | | | | | | | | | — | | | | | | — | | |
Two or More Races or Ethnicities
|
| | | | — | | | | | | — | | | | | | | | | | | | — | | | | | | — | | |
LGBTQ+
|
| | | | | | | | | | | | | | | | — | | | | | | | | | | | | | | |
Did Not Disclose Demographic Background
|
| | | | | | | | | | | | | | | | — | | | | | | | | | | | | | | |
Name
|
| |
Positions and Offices Held with Entrada
|
| |
Director
Since |
| |
Age
|
|
Dipal Doshi | | | Chief Executive Officer, President, Director | | |
2017
|
| |
46
|
|
Kush M. Parmar, M.D., Ph.D. | | | Board Chairman, Director | | |
2016
|
| |
41
|
|
Mary Thistle | | | Director | | |
2021
|
| |
62
|
|
Name
|
| |
Position and Offices Held with Entrada
|
| |
Director
Since |
| |
Class and Year in
Which Term Will Expire |
| |
Age
|
|
Peter S. Kim, Ph.D. | | | Director | | |
2020
|
| |
Class II – 2023
|
| |
63
|
|
Carole Nuechterlein | | | Director | | |
2020
|
| |
Class II – 2023
|
| |
61
|
|
John F. Crowley | | | Director | | |
2019
|
| |
Class III – 2024
|
| |
54
|
|
Todd Foley | | | Director | | |
2018
|
| |
Class III – 2024
|
| |
50
|
|
Name
|
| |
Position and Offices Held with Entrada
|
| |
Officer
Since |
| |
Age
|
|
Nathan J. Dowden | | | Chief Operating Officer | | |
2019
|
| |
52
|
|
Nerissa C. Kreher, M.D. | | | Chief Medical Officer | | |
2020
|
| |
49
|
|
Natarajan Sethuraman, Ph.D. | | | Chief Scientific Officer | | |
2017
|
| |
60
|
|
Kory Wentworth | | | Chief Financial Officer | | |
2020
|
| |
43
|
|
Fee Category
|
| |
Fiscal Year
2021 ($) |
| |
Fiscal Year
2020 ($) |
| ||||||
Audit Fees(1)
|
| | | | 1,614,261 | | | | | | 150,000 | | |
Audit-Related Fees(2)
|
| | | | — | | | | | | — | | |
Tax Fees(3)
|
| | | | 9,000 | | | | | | — | | |
All Other Fees(4)
|
| | | | — | | | | | | — | | |
Total Fees
|
| | | | 1,623,261 | | | | | | 150,000 | | |
NAME AND PRINCIPAL POSITION
|
| |
YEAR
|
| |
SALARY
($) |
| |
BONUS
($)(1) |
| |
STOCK
AWARDS ($) |
| |
OPTION
AWARDS ($)(2) |
| |
NON-EQUITY
INCENTIVE PLAN COMPENSATION ($)(3) |
| |
ALL OTHER
COMPENSATION ($) |
| |
TOTAL
($) |
| ||||||||||||||||||||||||
Dipal Doshi
President and Chief Executive Officer |
| | | | 2021 | | | | | | 425,057 | | | | | | 117,500 | | | | | | — | | | | | | 4,742,292 | | | | | | 233,050 | | | | | | 12,500(4) | | | | | | 5,530,399 | | |
| | | 2020 | | | | | | 385,000 | | | | | | | | | | | | — | | | | | | 310,753 | | | | | | 134,750 | | | | | | 75,000(5) | | | | | | 905,503 | | | ||
Natarajan Sethuraman Ph. D.
Chief Scientific Officer |
| | | | 2021 | | | | | | 382,939 | | | | | | 60,000 | | | | | | — | | | | | | 3,684,745 | | | | | | 178,930 | | | | | | — | | | | | | 4,306,614 | | |
| | | 2020 | | | | | | 359,625 | | | | | | — | | | | | | — | | | | | | 93,965 | | | | | | 126,175 | | | | | | — | | | | | | 579,765 | | | ||
Nathan Dowden
Chief Operating Officer |
| | | | 2021 | | | | | | 378,532 | | | | | | 50,000 | | | | | | — | | | | | | 1,706,565 | | | | | | 176,920 | | | | | | — | | | | | | 2,312,017 | | |
| | | 2020 | | | | | | 354,488 | | | | | | — | | | | | | — | | | | | | 82,636 | | | | | | 124,373 | | | | | | — | | | | | | 561,497 | | |
| | |
Options Awards
|
| |
Stock Awards
|
| ||||||||||||||||||||||||||||||||||||
Name
|
| |
Vesting
Commencement Date(1) |
| |
Number Of
Securities Underlying Unexercised Options (#) Exercisable(2) |
| |
Number Of
Securities Underlying Unexercised Options (#) Unexercisable |
| |
Option
Exercise Price ($) |
| |
Option
Expiration Date |
| |
Number Of
Shares Or Units Of Stock That Have Not Vested (#) |
| |
Market
Value Of Shares Or Units Of Stock That Have Not Vested ($) |
| |||||||||||||||||||||
Dipal Doshi
|
| | | | 12/31/2018(3) | | | | | | 409,989 | | | | | | — | | | | | | 1.74 | | | | | | 5/14/2029 | | | | | | 14,393(6) | | | | | | 246,408 | | |
| | | | | 8/12/2020 | | | | | | 140,362 | | | | | | — | | | | | | 2.10 | | | | | | 12/16/2030 | | | | | | | | | | | | | | |
| | | | | 3/30/2021 | | | | | | 312,750 | | | | | | — | | | | | | 8.47 | | | | | | 5/19/2031 | | | | | | | | | | | | | | |
| | | | | 8/2/2021 | | | | | | 82,920 | | | | | | — | | | | | | 12.52 | | | | | | 8/2/2031 | | | | | | | | | | | | | | |
| | | | | 10/28/2021(5) | | | | | | 7,701 | | | | | | 177,120 | | | | | | 20.00 | | | | | | 10/27/2031 | | | | | | | | | | | | | | |
Natarajan Sethuraman, Ph.D
|
| | | | 3/4/2019(4) | | | | | | 68,312 | | | | | | — | | | | | | 1.74 | | | | | | 3/5/2029 | | | | | | | | | | | | | | |
| | | | | 8/12/2020 | | | | | | 10,284 | | | | | | — | | | | | | 2.10 | | | | | | 12/16/2030 | | | | | | 28,340(7) | | | | | | 485,181 | | |
| | | | | 3/30/2021 | | | | | | 96,377 | | | | | | — | | | | | | 8.47 | | | | | | 5/19/2031 | | | | | | | | | | | | | | |
| | | | | 8/2/2021 | | | | | | 4,146 | | | | | | — | | | | | | 12.52 | | | | | | 8/2/2031 | | | | | | | | | | | | | | |
| | | | | 10/28/2021(5) | | | | | | 10,152 | | | | | | 233,487 | | | | | | 20.00 | | | | | | 10/27/2031 | | | | | | | | | | | | | | |
Nathan Dowden
|
| | | | 12/10/2019(4) | | | | | | 84,831 | | | | | | — | | | | | | 1.74 | | | | | | 12/10/2029 | | | | | | | | | | | | | | |
| | | | | 8/12/2020 | | | | | | 46,117 | | | | | | — | | | | | | 2.10 | | | | | | 12/16/2030 | | | | | | | | | | | | | | |
| | | | | 3/30/2021 | | | | | | 82,973 | | | | | | — | | | | | | 8.47 | | | | | | 5/19/2031 | | | | | | | | | | | | | | |
| | | | | 8/2/2021 | | | | | | 4,146 | | | | | | — | | | | | | 12.52 | | | | | | 8/2/2031 | | | | | | | | | | | | | | |
| | | | | 10/28/2021(5) | | | | | | 3,965 | | | | | | 91,183 | | | | | | 20.00 | | | | | | 10/27/2031 | | | | | | | | | | | | | | |
| | |
Fees Earned
or Paid in Cash ($) |
| |
Option
Awards ($)(1) |
| |
All Other
Compensation ($) |
| |
Total ($)
|
| ||||||||||||
Peter S. Kim(2)
|
| | | | 35,417 | | | | | | 218,086 | | | | | | — | | | | | | 308,681 | | |
John F. Crowley(3)
|
| | | | 37,583 | | | | | | 218,086 | | | | | | — | | | | | | 293,241 | | |
Mary Thistle(4)
|
| | | | 27,125 | | | | | | 395,624 | | | | | | — | | | | | | 422,749 | | |
Kush M. Parmar(5)
|
| | | | 13,167 | | | | | | 290,572 | | | | | | — | | | | | | 303,739 | | |
Todd Foley(6)
|
| | | | 7,917 | | | | | | 290,572 | | | | | | — | | | | | | 298,489 | | |
| | |
Fees Earned
or Paid in Cash ($) |
| |
Option
Awards ($)(1) |
| |
All Other
Compensation ($) |
| |
Total ($)
|
| ||||||||||||
Carole Nuechterlein(7)
|
| | | | 8,333 | | | | | | 290,572 | | | | | | — | | | | | | 298,905 | | |
Position
|
| |
Annual
Retainer |
| |||
Board of Directors: | | | | | | | |
Members (other than chair)
|
| | | $ | 37,500 | | |
Retainer for chair
|
| | | $ | 30,000 | | |
Audit Committee: | | | | | | | |
Members (other than chair)
|
| | | $ | 7,500 | | |
Retainer for chair
|
| | | $ | 15,000 | | |
Compensation Committee: | | | | | | | |
Members (other than chair)
|
| | | $ | 5,000 | | |
Retainer for chair
|
| | | $ | 10,000 | | |
Nominating and Corporate Governance Committee: | | | | | | | |
Members (other than chair)
|
| | | $ | 4,000 | | |
Position
|
| |
Annual
Retainer |
| |||
Retainer for chair
|
| | | $ | 8,000 | | |
Participant
|
| |
Shares of
Series B Preferred Stock |
| |
Total Purchase
Price ($) |
| ||||||
Entities affiliated with 5AM Ventures(1)
|
| | | | 4,143,646 | | | | | $ | 8,999,999.11 | | |
Entities affiliated with MPM Capital(2)
|
| | | | 3,683,241 | | | | | $ | 7,999,999.45 | | |
Roche Finance Ltd(3)
|
| | | | 2,302,026 | | | | | $ | 5,000,000.47 | | |
Purchaser
|
| |
Shares of
Common Stock Purchased |
| |
Aggregate
Purchase Price |
| ||||||
Entities affiliated with MPM Capital
|
| | | | 100,000 | | | | | $ | 2,000,000 | | |
Entities affiliated with 5AM Ventures
|
| | | | 250,000 | | | | | $ | 5,000,000 | | |
Name of Beneficial Owner
|
| |
Shares
Beneficially Owned |
| |
Percentage of
Shares Beneficially Owned |
| ||||||
Greater-than-5% Stockholders: | | | | | | | | | | | | | |
Baker Bros. Advisors LP(1)
|
| | | | 4,704,419 | | | | | | 15.00% | | |
Entities affiliated with MPM Capital(2)
|
| | | | 4,425,784 | | | | | | 14.11% | | |
Entities affiliated with 5AM Ventures(3)
|
| | | | 4,408,379 | | | | | | 14.06% | | |
MRL Ventures Fund, LLC(4)
|
| | | | 1,739,768 | | | | | | 5.55% | | |
Redmile Group, LLC(5)
|
| | | | 1,954,420 | | | | | | 6.23% | | |
Roche Finance Ltd (6)
|
| | | | 2,813,525 | | | | | | 8.97% | | |
T. Rowe Price Associates, Inc.(7)
|
| | | | 2,020,637 | | | | | | 6.44% | | |
Wellington Management Group LLP(8)
|
| | | | 3,114,006 | | | | | | 9.93% | | |
Named Executive Officers and Directors: | | | | | | | | | | | | | |
Dipal Doshi, President, Chief Executive Officer and Director(9)
|
| | | | 1,147,434 | | | | | | 3.55% | | |
Kory Wentworth, Chief Financial Officer(10)
|
| | | | 222,248 | | | | | | * | | |
Nathan J. Dowden, Chief Operating Officer(11)
|
| | | | 293,287 | | | | | | * | | |
Nerissa C. Kreher, M.D., Chief Medical Officer(12)
|
| | | | 222,250 | | | | | | * | | |
Natarajan Sethuraman, Ph.D., Chief Scientific Officer(13)
|
| | | | 359,412 | | | | | | 1.14% | | |
John F. Crowley, Director(14)
|
| | | | 52,044 | | | | | | * | | |
Todd Foley, Director(2)(15)
|
| | | | 4,580 | | | | | | * | | |
Peter S. Kim, Ph.D., Director(16)
|
| | | | 47,044 | | | | | | * | | |
Carole Nuechterlein, Director (17)
|
| | | | 4,580 | | | | | | * | | |
Kush M. Parmar, M.D., Ph.D., Chairman(3)(18)
|
| | | | 4,580 | | | | | | * | | |
Mary Thistle, Director(19)
|
| | | | 46,604 | | | | | | * | | |
All executive officers and directors as a group (11 persons)(20)
|
| | | | 2,404,063 | | | | | | 7.22% | | |